Anileridinum [Inn-Latin]
Brand names,
Anileridinum [Inn-Latin]
Analogs
Anileridinum [Inn-Latin]
Brand Names Mixture
Anileridinum [Inn-Latin]
Chemical_Formula
C22H28N2O2
Anileridinum [Inn-Latin]
RX_link
No information avaliable
Anileridinum [Inn-Latin]
fda sheet
Anileridinum [Inn-Latin]
msds (material safety sheet)
Anileridinum [Inn-Latin]
Synthesis Reference
Weijlard et al., J. Am. Chem. Soc. 78, 2342 (1956)
Anileridinum [Inn-Latin]
Molecular Weight
352.47 g/mol
Anileridinum [Inn-Latin]
Melting Point
83 oC
Anileridinum [Inn-Latin]
H2O Solubility
No information avaliable
Anileridinum [Inn-Latin]
State
Solid
Anileridinum [Inn-Latin]
LogP
4.384
Anileridinum [Inn-Latin]
Dosage Forms
Liquid; Tablet
Anileridinum [Inn-Latin]
Indication
For treatment and management of pain (systemic) and for use as an anesthesia adjunct.
Anileridinum [Inn-Latin]
Pharmacology
Anileridine, a potent analgesic, is an analog of pethidine. Anileridine is useful for the relief of moderate to severe pain. It may also be used as an analgesic adjunct in general anesthesia in the same manner as meperidine to reduce the amount of anesthetic needed, to facilitate relaxation, and to reduce laryngospasm. In addition, anileridine exerts mild antihistaminic, spasmolytic and antitussive effects. Anileridine's main pharmacologic action is exerted on the CNS. Respiratory depression, when it occurs, is of shorter duration than that seen with morphine or meperidine when equipotent analgesic doses are used.
Anileridinum [Inn-Latin]
Absorption
Anileridine is absorbed by all routes of administration.
Anileridinum [Inn-Latin]
side effects and Toxicity
Symptoms of overexposure include dizziness, perspiration, a feeling of warmth, dry mouth, visual difficulty, itching, euphoria, restlessness, nervousness and excitement have been reported.
Anileridinum [Inn-Latin]
Patient Information
No information avaliable
Anileridinum [Inn-Latin]
Organisms Affected
Humans and other mammals